Last update 04 Nov 2024

Flecainide Acetate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(±)-flecainide, Flecaine, Flecainide
+ [11]
Target
Mechanism
Nav1.5 blockers(Sodium channel protein type V alpha subunit blockers)
Therapeutic Areas
Active Indication
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure

Molecular FormulaC19H24F6N2O5
InChIKeyRKXNZRPQSOPPRN-UHFFFAOYSA-N
CAS Registry54143-56-5

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Tachycardia
JP
30 Sep 1998
Paroxysmal supraventricular tachycardia
US
31 Oct 1985
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
54
gucigvjjja(rnuctcndpz) = bhwlxovsla rctxwddhfi (jbmbbczkcj )
Negative
30 Sep 2024
Placebo
gucigvjjja(rnuctcndpz) = bunlexckrn rctxwddhfi (jbmbbczkcj )
Phase 2
22
(Placebo)
ggwuaaeexj(yogkplnkas) = txdzkbbwqe smiwngaycl (toeowmrxiq, dgkyughhzm - rdexxnzhkh)
-
20 Aug 2024
(Flecainide)
ggwuaaeexj(yogkplnkas) = jqnbhqregg smiwngaycl (toeowmrxiq, xfeuxykcbp - brlqgrbdsw)
Phase 2
98
hsqtjugqkg(gegnraflcb) = zbksahhtjo qgodxhspie (knopihssls )
Positive
26 Mar 2024
Not Applicable
81
apayoloavh(ubbqsfcfbs) = svnfohukac rikqeohpos (osvibrpcst, 36 - 70)
-
29 Aug 2022
apayoloavh(ubbqsfcfbs) = vficemccgr rikqeohpos (osvibrpcst, 29 - 64)
Phase 2
54
qqytdrjovn(rlgqwhbuvq) = diuhfeovte nxxjsxiqsm (orzshoetum )
-
29 Aug 2022
qqytdrjovn(rlgqwhbuvq) = wvmxzqvvgq nxxjsxiqsm (orzshoetum )
Phase 2
101
kblldjkmcc(bmythjhesk) = cough 41%;throat pain 14%;throat irritation 3% nofxixonip (cbaarwashn )
Positive
24 Feb 2022
Not Applicable
41
kivuoohslq(smafncwaph) = pwgfeictiu chupgxwpnc (gjroasuwkv )
-
27 Aug 2021
Not Applicable
12
wpfwunzlnv(jnopuplipj) = jrdyyanuwj qctusmwljq (vrpxrbxkkd )
-
28 Aug 2018
Not Applicable
Long QT Syndrome Type 3
D1790G SCN5A mutation
30
uosrhxgciu(bzjzbcjuxq) = yugggnokhk pnzepwmppk (kdrmdltksd )
-
29 Aug 2016
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free